Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,951 public trials 2,018 recruiting studies

Immunoproliferative Disorders trial results

Conditions
Aggressive B-Cell Non-Hodgkin Lymphoma, B Cell Lymphoma, Blood Protein Disorders, +54 more
Locations
  • Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute Denver, Colorado, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • The University of Kansas Cancer Center Fairway, Kansas, United States
  • Rutgers Cancer Institute New Brunswick, New Jersey, United States
Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Beijing Chao-Yang Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
  • Qilu Hospital of Shandong University Jinan, Shandong, China
  • Institute of Hematology & Blood Diseases Hospital,Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
Conditions
Advanced Solid Tumor, Bone Diseases, Bone Diseases, Developmental, +15 more
Locations
  • Prisma Health-Upstate Greenville, South Carolina, United States
  • The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, China
  • Zhejiang Provincial Cancer Hospital Hangzhou, China
  • Xuzhou Central Hospital Xuzhou, China
Conditions
ART, Abruptio Placentae, Cardiovascular Diseases, +50 more
Locations
  • Copenhagen Fertility Center Copenhagen, Denmark
  • Trianglen Fertility Clinic Hellerup, Denmark
  • Fertility Clinic, Herlev / Gentofte Hospital Herlev, Denmark
  • Sellmer Klinik København S, Denmark